Trial Profile
A Randomized Study Evaluating Dapagliflozin and Metformin, Alone and in Combination, in Overweight Women With a Recent History of Gestational Diabetes Mellitus: Effects on Anthropometric Measurements and Cardiometabolic Abnormalities
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Dapagliflozin/metformin (Primary) ; Dapagliflozin; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms DAPA-GDM
- 05 Apr 2019 Status changed from active, no longer recruiting to completed.
- 07 Mar 2019 Planned End Date changed from 1 Mar 2019 to 30 Apr 2019.
- 07 Feb 2019 Planned primary completion date changed from 1 Feb 2019 to 13 Feb 2019.